The Effect of Lubiprostone, a Chloride Channel Activator, on Colonic Sensorimotor Functions in Healthy Subjects. A Phase IV, Placebo-Controlled, Parallel Group Study.

Trial Profile

The Effect of Lubiprostone, a Chloride Channel Activator, on Colonic Sensorimotor Functions in Healthy Subjects. A Phase IV, Placebo-Controlled, Parallel Group Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation; Irritable bowel syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Feb 2012 Actual end date changed from Mar 2009 to Jul 2009as reported by ClinicalTrials.gov.
    • 24 Feb 2012 Actual initiation date changed from Apr 2007 to Sep 2007 as reported by ClinicalTrials.gov.
    • 08 Feb 2012 Additional lead trial centres identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top